| First Author | Garcia-Bonilla L | Year | 2016 |
| Journal | J Neuroinflammation | Volume | 13 |
| Issue | 1 | Pages | 285 |
| PubMed ID | 27814740 | Mgi Jnum | J:384847 |
| Mgi Id | MGI:8308937 | Doi | 10.1186/s12974-016-0750-0 |
| Citation | Garcia-Bonilla L, et al. (2016) Spatio-temporal profile, phenotypic diversity, and fate of recruited monocytes into the post-ischemic brain. J Neuroinflammation 13(1):285 |
| abstractText | BACKGROUND: A key feature of the inflammatory response after cerebral ischemia is the brain infiltration of blood monocytes. There are two main monocyte subsets in the mouse blood: CCR2(+)Ly6C(hi) "inflammatory" monocytes involved in acute inflammation, and CX3CR1(+)Ly6C(lo) "patrolling" monocytes, which may play a role in repair processes. We hypothesized that CCR2(+)Ly6C(hi) inflammatory monocytes are recruited in the early phase after ischemia and transdifferentiate into CX3CR1(+)Ly6C(lo) "repair" macrophages in the brain. METHODS: CX3CR1(GFP/+)CCR2(RFP/+) bone marrow (BM) chimeric mice underwent transient middle cerebral artery occlusion (MCAo). Mice were sacrificed from 1 to 28 days later to phenotype and map subsets of infiltrating monocytes/macrophages (Mo/MPhi) in the brain over time. Flow cytometry analysis 3 and 14 days after MCAo in CCR2(-/-) mice, which exhibit deficient monocyte recruitment after inflammation, and NR4A1(-/-) BM chimeric mice, which lack circulating CX3CR1(+)Ly6C(lo) monocytes, was also performed. RESULTS: Brain mapping of CX3CR1(GFP/+) and CCR2(RFP/+) cells 3 days after MCAo showed absence of CX3CR1(GFP/+) Mo/MPhi but accumulation of CCR2(RFP/+) Mo/MPhi throughout the ischemic territory. On the other hand, CX3CR1(+) cells accumulated 14 days after MCAo at the border of the infarct core where CCR2(RFP/+) accrued. Whereas the amoeboid morphology of CCR2(RFP/+) Mo/MPhi remained unchanged over time, CX3CR1(GFP/+) cells exhibited three distinct phenotypes: amoeboid cells with retracted processes, ramified cells, and perivascular elongated cells. CX3CR1(GFP/+) cells were positive for the Mo/MPhi marker Iba1 and phenotypically distinct from endothelial cells, smooth muscle cells, pericytes, neurons, astrocytes, or oligodendrocytes. Because accumulation of CX3CR1(+)Ly6C(lo) Mo/MPhi was absent in the brains of CCR2 deficient mice, which exhibit deficiency in CCR2(+)Ly6C(hi) Mo/MPhi recruitment, but not in NR4A1(-/-) chimeric mice, which lack of circulating CX3CR1(+)Ly6C(lo) monocytes, our data suggest a local transition of CCR2(+)Ly6C(hi) Mo/MPhi into CX3CR1(+)Ly6C(lo) Mo/MPhi phenotype. CONCLUSIONS: CX3CR1(+)Ly6C(lo) arise in the brain parenchyma from CCR2(+)Ly6C(hi) Mo/MPhi rather than being de novo recruited from the blood. These findings provide new insights into the trafficking and phenotypic diversity of monocyte subtypes in the post-ischemic brain. |
